PharmaceuticalCompanies
List your company
CompaniesCDMOsAPIGeographyShortagesPatent cliff
Register entry

Lonza Biologics Inc

Request a quoteClaim this profile
Registered sites
15
Drug products
80
Live patents
0
Countries
7
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites

Facilities

15
SiteLocationOperationsFEI
Lonza AGBaselSwitzerlandAnalytical testing3014753648
Lonza AGStein AGSwitzerlandAnalytical testing, Finished drug manufacture3016502617
Lonza AGVispSwitzerlandAnalytical testing, Active ingredient (API) manufacture3002930340
Lonza AGVispSwitzerlandAnalytical testing, Active ingredient (API) manufacture, Finished drug manufacture3012793444
Lonza Guangzhou Pharmaceutical Ltd.GuangzhouChinaAnalytical testing, Active ingredient (API) manufacture3006532186
Lonza Biologics Porrino SLO PORRI�OSpainAnalytical testing, Active ingredient (API) manufacture3006067169
Lonza Biologics, plcSloughUnited KingdomAnalytical testing, Active ingredient (API) manufacture1000583959
Lonza Netherlands B.V.GeleenNetherlandsAnalytical testing, Labelling, Finished drug manufacture, Packaging3014382532
LONZA BIOLOGICS TUAS PTE. LTD.SingaporeSingaporeAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3009725845
Lonza Bend Inc.Bend, ORUnited StatesAnalytical testing, Finished drug manufacture3003722743
Lonza Bend Inc.Bend, ORUnited StatesAnalytical testing1000656789
Lonza Houston, IncHouston, TXUnited StatesAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3013629214
Lonza Biologics, Inc.Portsmouth, NHUnited StatesAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3001451441
Lonza Tampa LLCTAMPA, FLUnited StatesAnalytical testing, Labelling, Finished drug manufacture, Packaging3001549109
Lonza Manufacturing LLCVacaville, CAUnited StatesAnalytical testing, Active ingredient (API) manufacture3032299571
Catalogue

Marketed products

80

Showing 80 of 80.

BrandGeneric nameFormCategory
-AFOXOLANERPOWDERBULK INGREDIENT
-AbemaciclibPOWDERBULK INGREDIENT
-ApremilastPOWDERBULK INGREDIENT
-Asfotase alfaLIQUIDDRUG FOR FURTHER PROCESSING
-AvacopanPOWDERBULK INGREDIENT
-BemelanotidePOWDERBULK INGREDIENT
-Benzalkonium ChlorideSOLUTION, CONCENTRATEDRUG FOR FURTHER PROCESSING
-Benzethonium ChloridePOWDERBULK INGREDIENT
-Benzethonium ChloridePOWDERBULK INGREDIENT
-BlinatumomabLIQUIDDRUG FOR FURTHER PROCESSING
-Brentuximab VedotinLIQUIDDRUG FOR FURTHER PROCESSING
-BrolucizumabSOLUTIONDRUG FOR FURTHER PROCESSING
-BurosumabLIQUIDDRUG FOR FURTHER PROCESSING
-Certolizumab pegolSOLUTIONDRUG FOR FURTHER PROCESSING
-EMAPALUMAB 25 mg/mlLIQUIDDRUG FOR FURTHER PROCESSING
-Efgartigimod Drug substanceLIQUIDDRUG FOR FURTHER PROCESSING
-Eftrenonacog alfaLIQUIDDRUG FOR FURTHER PROCESSING
-Eslicarbazepin acetatePOWDERBULK INGREDIENT
-FirocoxibPOWDERBULK INGREDIENT
-FremanezumabLIQUIDDRUG FOR FURTHER PROCESSING
-GABAPENTIN ENACARBILPOWDERBULK INGREDIENT
-ISATUXIMABLIQUIDDRUG FOR FURTHER PROCESSING
-Infliximab 40.0 mg/mL Drug SubstanceLIQUIDDRUG FOR FURTHER PROCESSING
-L-AsparaginaseSOLUTIONDRUG FOR FURTHER PROCESSING
-LENALIDOMIDEPOWDERBULK INGREDIENT
-LENALIDOMIDEPOWDERBULK INGREDIENT
-LISOCABTAGENE MARALEUCEL LENTIVIRUS VECTORSUSPENSIONDRUG FOR FURTHER PROCESSING
-Lonapegsomatropin-TCGDSOLUTIONDRUG FOR FURTHER PROCESSING
-LufenuronPOWDERBULK INGREDIENT
-Lumateperone tosylatePOWDERBULK INGREDIENT
-Lumateperone tosylate non mcPOWDERBULK INGREDIENT
-MabYLIQUIDDRUG FOR FURTHER PROCESSING
-Macitentan micronizedPOWDERBULK INGREDIENT
-Macitentan non-micronizedPOWDERDRUG FOR FURTHER PROCESSING
-MecaserminSOLUTIONDRUG FOR FURTHER PROCESSING
-Mepolizumab Drug SubstanceLIQUIDDRUG FOR FURTHER PROCESSING
-MiglustatPOWDERBULK INGREDIENT
-MomelotinibPOWDERBULK INGREDIENT
-NI-0501 6 mg/mlLIQUIDDRUG FOR FURTHER PROCESSING
-ObiltoxaximabLIQUIDDRUG FOR FURTHER PROCESSING
-OfatumumabLIQUIDDRUG FOR FURTHER PROCESSING
-OlaparibPOWDERBULK INGREDIENT
-OlaparibPOWDERBULK INGREDIENT
-Osimertinib mesylatePOWDERBULK INGREDIENT
-Osimetinib mesylatePOWDERBULK INGREDIENT
-PMT TildipirosinPOWDERBULK INGREDIENT
-Polatuzumab vedotinLIQUIDDRUG FOR FURTHER PROCESSING
-RapamycinPOWDERBULK INGREDIENT
-RepotrectinibPOWDERBULK INGREDIENT
-Rosuvastatin calciumPOWDERBULK INGREDIENT
-Rucaparib camsylatePOWDERBULK INGREDIENT
-Sacituzumab GovitecanLIQUIDDRUG FOR FURTHER PROCESSING
-Sonidegib diphosphatePOWDERBULK INGREDIENT
-TafasitamabLIQUIDDRUG FOR FURTHER PROCESSING
-TicagrelorPOWDERBULK INGREDIENT
-Tisotumab vedotinLIQUIDDRUG FOR FURTHER PROCESSING
-TocilizumabLIQUIDDRUG FOR FURTHER PROCESSING
-Trastuzumab EmtansineLIQUIDDRUG FOR FURTHER PROCESSING
-Trastuzumab/DeruxtecanLIQUIDDRUG FOR FURTHER PROCESSING
-Vedolizumab IVLIQUIDDRUG FOR FURTHER PROCESSING
-Vedolizumab SCLIQUIDDRUG FOR FURTHER PROCESSING
-VoclosporinPOWDERBULK INGREDIENT
-Zibotentan (micronized)POWDERBULK INGREDIENT
-efgartigimodLIQUIDDRUG FOR FURTHER PROCESSING
-enfortumab vedotinLIQUIDDRUG FOR FURTHER PROCESSING
-mPEG-7-OMs 2,5,8,11,14,17,20-Heptaoxadocosan-22-yl methanesulfonateLIQUIDBULK INGREDIENT
-mogamulizumabLIQUIDDRUG FOR FURTHER PROCESSING
-ocrelizumabLIQUIDDRUG FOR FURTHER PROCESSING
-ocrelizumabLIQUIDDRUG FOR FURTHER PROCESSING
-pertuzumabLIQUIDDRUG FOR FURTHER PROCESSING
-pertuzumabLIQUIDDRUG FOR FURTHER PROCESSING
-pertuzumabLIQUIDDRUG FOR FURTHER PROCESSING
-rADA (Deaminase, adenosine)SOLUTIONDRUG FOR FURTHER PROCESSING
-rituximabLIQUIDDRUG FOR FURTHER PROCESSING
-rituximabLIQUIDDRUG FOR FURTHER PROCESSING
-tisotumabLIQUIDDRUG FOR FURTHER PROCESSING
-tividenofusp alfa-eknmSOLUTIONDRUG FOR FURTHER PROCESSING
-tocilizumabLIQUIDDRUG FOR FURTHER PROCESSING
-vandetanibPOWDERBULK INGREDIENT
-vandetanib non-mcPOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.